Aperam


Q124: weak as expected and a downwards revision of our estimates.

06/05/24 -"The Q124 results came as no surprise, i.e. continued to reflect the weakness in the market. In the light of teh Q2 which is expected to be in the same vein, our forecasts are too high and we will ..."

Pages
61
Language
English
Published on
06/05/24
You may also be interested by these reports :
24/05/24
Undemanding expectations leave room for upside

22/05/24
BHP made its third offer for Anglo earlier today, proposing £38.6bn as the revised valuation, but with the reinforcement of the South African ...

22/05/24
Animal spirits have returned to Mining stocks. The following commentary excludes Steel stocks which were commented upon on 21-05. Hot Mining stocks ...

15/05/24
A mixed bag with a negative touch – Decline in sales and negative net profit

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO